Mustgrow Biologics Corp
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home … Read more
Market Cap & Net Worth: Mustgrow Biologics Corp (MGROF)
Mustgrow Biologics Corp (OTCQB:MGROF) has a market capitalization of $45.00 Million ($45.00 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #24686 globally and #8495 in its home market, demonstrating a -8.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mustgrow Biologics Corp's stock price $0.72 by its total outstanding shares 62854357 (62.85 Million).
Mustgrow Biologics Corp Market Cap History: 2019 to 2025
Mustgrow Biologics Corp's market capitalization history from 2019 to 2025. Data shows growth from $30.59 Million to $45.00 Million (7.32% CAGR).
Mustgrow Biologics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mustgrow Biologics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
194.24x
Mustgrow Biologics Corp's market cap is 194.24 times its annual revenue
0.23x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $190.45 Million | $12.87K | -$3.06 Million | 14799.03x | N/A |
| 2022 | $161.54 Million | $6.48K | -$5.57 Million | 24932.20x | N/A |
| 2023 | $60.97 Million | $4.71 Million | -$676.94K | 12.94x | N/A |
| 2024 | $77.31 Million | $398.02K | -$4.89 Million | 194.24x | N/A |
Competitor Companies of MGROF by Market Capitalization
Companies near Mustgrow Biologics Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Mustgrow Biologics Corp by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
Mustgrow Biologics Corp Historical Marketcap From 2019 to 2025
Between 2019 and today, Mustgrow Biologics Corp's market cap moved from $30.59 Million to $ 45.00 Million, with a yearly change of 7.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $45.00 Million | -41.79% |
| 2024 | $77.31 Million | +26.80% |
| 2023 | $60.97 Million | -62.26% |
| 2022 | $161.54 Million | -15.18% |
| 2021 | $190.45 Million | +210.01% |
| 2020 | $61.43 Million | +100.82% |
| 2019 | $30.59 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Mustgrow Biologics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.00 Million USD |
| MoneyControl | $45.00 Million USD |
| MarketWatch | $45.00 Million USD |
| marketcap.company | $45.00 Million USD |
| Reuters | $45.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.